Wolverine Asset Management’s Haemonetics HAE Stock Holding History

Wolverine Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30K	Hold	400	–	–	﹤0.01%	1325
2026 Q1	$22.5K	Hold	400	–	–	﹤0.01%	1360
2025 Q4	$32.1K	Sell	400 -10,500	-96%	-$705K	﹤0.01%	1327
2025 Q3	$531K	Buy	10,900 +8,100	+289%	+$501K	﹤0.01%	864
2025 Q2	$209K	Buy	+2,800	New	+$185K	﹤0.01%	1021
2024 Q1	–	Sell	-3,300	Closed	-$282K	–	1768
2023 Q4	$282K	Sell	3,300 -11,100	-77%	-$960K	﹤0.01%	988
2023 Q3	$1.29M	Buy	14,400 +4,100	+40%	+$366K	0.01%	658
2023 Q2	$877K	Buy	10,300 +2,000	+24%	+$169K	0.01%	718
2023 Q1	$687K	Buy	8,300 +3,400	+69%	+$275K	0.01%	787
2022 Q4	$385K	Buy	4,900 +1,800	+58%	+$145K	﹤0.01%	1015
2022 Q3	$229K	Buy	+3,100	New	+$223K	﹤0.01%	1205
2021 Q4	–	Sell	-13,600	Closed	-$960K	–	2115
2021 Q3	$960K	Sell	13,600 -10,000	-42%	-$631K	0.01%	742
2021 Q2	$1.57M	Buy	+23,600	New	+$1.67M	0.01%	501

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Asset Management's HAE Position: Q2 2026 in Review

Wolverine Asset Management sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 671 shares — an estimated $43.1K sold.

Wolverine Asset Management first reported a position in HAE in Q2 2021 and held it in 6 quarters. The position peaked at $1.43M in Q2 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Wolverine Asset Management reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
Wolverine Asset Management sold 671 Haemonetics shares in Q2 2026, an estimated $43.1K.
Wolverine Asset Management first reported a position in Haemonetics in Q2 2021 and held it in 6 quarters.
Wolverine Asset Management's Haemonetics position peaked at $1.43M in Q2 2024.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.